WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2011> 22> 4

Volume: 22 Issue: 4

1. The role of neoadjuvant chemotherapy in ovarian cancer patients with extensive tumor burden. Page:299—300
2. Paratubal serous borderline tumor. Page:295—298
3. Long-term recurrence-free survival in a patient with stage IVB uterine carcinosarcoma. Page:292—294
4. A mediastinal germ cell tumor mimicking an ectopic pregnancy. Page:288—291
5. Diffusion-weighted MR imaging in gynecologic cancers. Page:275—287
6. Prediction of a high-risk group based on postoperative nadir CA-125 levels in patients with advanced epithelial ovarian cancer. Page:269—274
7. Thoracic metastasis in advanced ovarian cancer: comparison between computed tomography and video-assisted thoracic surgery. Page:260—268
8. Total laparoscopic hysterectomy versus da Vinci robotic hysterectomy: is using the robot beneficial?. Page:253—259
9. Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass. Page:244—252
10. Survival outcome of women with synchronous cancers of endometrium and ovary: a 10 year retrospective cohort study. Page:239—243
11. Synchronous gynecologic malignancy and preliminary results of Lynch syndrome. Page:233—238
12. Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro. Page:225—232
13. ASGO's Second Biennial Meeting, November 3-5 2011. Page:222—224
14. Recent advances in the biomarkers for epithelial ovarian cancer. Page:219—221